Clinical Trial Update: The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit [Phase 3]

View source ↗

Summary

Phase 3 trial investigating naloxegol for refractory constipation in critically ill patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Critical Illness

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Constipation, Critical Illness | Phase 3 | Status: WITHDRAWN